Related Experiment Video
Updated: Apr 29, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
Nicotine alters mucin rheological properties
Eric Y Chen1, Albert Sun2, Chi-Shuo Chen2
1Bioengineering, University of California at Merced, Merced, California; Center for Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan; and MicroBase Technology Corporation, Taoyuan, Taiwan.
Nicotine in tobacco smoke directly increases mucus viscosity by hindering hydration, contributing to chronic obstructive pulmonary disease (COPD). This finding highlights risks associated with secondhand smoke exposure.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Cell Biology
Background:
- Tobacco smoke is the primary cause of chronic obstructive pulmonary disease (COPD).
- Dysfunctional clearance of thick mucus is a hallmark of COPD, but the underlying mechanisms remain unclear.
- Nicotine's direct impact on mucus rheology has not been fully elucidated.
Purpose of the Study:
- To investigate the direct effects of nicotine on the physicochemical properties of human airway mucin.
- To determine if nicotine alters mucin gel viscosity and hydration.
- To explore the potential of airway mucus acting as a reservoir for nicotine.
Main Methods:
- Human airway mucin gels were secreted from A549 lung epithelial cells.
- Swelling kinetics and multiple particle tracking were used to measure changes in mucin gel viscosity.
- Physicochemical interactions between nicotine and mucins were examined.
Main Results:
- Nicotine, even at low concentrations (≤50 nM), significantly reduced postexocytotic swelling and hydration of released mucins.
- This hindered hydration led to a marked increase in mucin gel viscosity.
- Evidence suggests electrostatic and hydrophobic interactions mediate nicotine's effect on mucins.
- Airway mucus was shown to act as a reservoir for prolonged nicotine release.
Conclusions:
- Nicotine directly increases airway mucus viscosity by impairing mucin hydration.
- This mechanism provides a novel explanation for mucus maltransport in smokers.
- The findings underscore the health risks of nicotine exposure, including from secondhand smoke.
- Targeting nicotine-mucin interactions could offer new therapeutic strategies for COPD.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

